approximately $13 billion.

ieCrowd’s 5 current innovations include:

Kite, which is being developed to block mosquitoes from finding and biting humans, with a goal of reducing human suffering from malaria, dengue fever, West Nile virus, and other mosquito-borne diseases

Nuuma, a nano based gas sensor being developed as a digital nose for mobile phones, wearables and other consumer, industrial and security uses

Smart Oxygen, an intelligent breathing device for COPD patients, and others who need supplemental oxygen

Head Pain Innovations, a non-pharma, non-invasive treatment for migraine and other head pain

Sleep Disorder Innovations, a non-pharma, non-invasive treatment for sleep disorders such as sleep apnea

In addition to these 5 innovations in development, ieCrowd recently secured options on an additional 28 patents and patent applications related to oncology, diabetes, bacterial infection and stroke.

ieCrowd was founded by experienced entrepreneurs who recognized that research institutions can be filled with un-commercialized discoveries (“innovations”) which, if successfully commercialized, could help to solve significant global challenges. The U.S. government spends $60 billion per year funding basic and applied research, creating a large pool of promising, untapped innovations. We believe the potential of these untapped innovations could be vast. Yet many of these innovations will never see the light of day.

Recognizing the gap between the marketplace and un-commercialized but potentially beneficial innovations, ieCrowd has built a collaborative economy business model intended to bridge this gap and bring untapped innovations out of the lab and turn them into future solutions.